AAV Tropism for Intestinal and GI Tissues

Targeting the intestines and the gastrointestinal (GI) tract is uniquely challenging because the virus must navigate a harsh acidic environment, thick mucus layers, and high cell turnover (the lining of your gut replaces itself every few days).

AAV tropism in the gut is typically divided into two categories: the Intestinal Epithelium (the lining for absorption/secretion) and the Enteric Nervous System (the “second brain” that controls digestion).

Serotype	Target Tissue/Cells	Transduction Efficiency	Optimal Route	Notes
AAV9	Enteric Neurons	Very High	Systemic (IV)	The most effective natural serotype for the “second brain.” High efficiency in the myenteric plexus.
AAV6	Epithelial Cells	High	Local (Enema)	Strong affinity for the mucosal lining; often used for inflammatory bowel disease (IBD) research.
AAV8	Hepatocytes & ENS	High	Systemic (IV)	Robust expression in the gut wall, though it has high “leakage” to the liver.
AAVrh10	Pan-intestinal	High	Local (SMA)	A primate strain that shows deep penetration into both the small intestine and colon.
AAV4	Enteroendocrine	Moderate	Local (SMA)	Shows a unique preference for specialized hormone-secreting cells in the gut lining.
AAV2	Epithelial Cells	Moderate	Local / Direct	The standard “workhorse” but often requires higher doses due to poor mucus penetration.
AAV-PHP.S	Enteric Neurons	Ultra High	Systemic (IV)	An engineered variant of AAV9 designed to target the peripheral nervous system with 10x more efficiency.

Overcoming the “Gut Barrier”

The route of delivery is the most critical factor for intestinal success. Most natural AAVs are destroyed by stomach acid, so oral delivery is rarely effective unless the virus is encapsulated.

1. Systemic (IV): Best for the Enteric Nervous System (ENS). AAV9 can cross from the blood into the deep nerve plexuses of the gut wall.
2. Superior Mesenteric Artery (SMA) Injection: A surgical route that “floods” the blood supply to the intestines. This provides the most uniform and deep transduction of the gut wall.
3. Intraluminal (Enema/Endoscopy): Best for the Epithelium. This route is non-invasive for the colon but struggle to reach the “crypts” where stem cells live because of the mucus barrier.

Intestine-Specific Promoters

Because the gut has very high cell turnover, targeting the intestinal stem cells is the “holy grail” for long-term therapy. To ensure specificity, researchers use:

• Villin: Restricts expression strictly to the Intestinal Brush Border (epithelium).
• MUC2 (Mucin 2): Targets Goblet Cells (the cells that produce mucus).
• hSyn (Human Synapsin): Used to restrict expression to Enteric Neurons, preventing expression in the surrounding smooth muscle.
• iFABP (Intestinal Fatty Acid Binding Protein): A potent promoter for targeting the small intestine.

A Note on “Stem Cell” Transduction

For long-term results in the gut lining, you must transduce the Lgr5+ stem cells at the base of the intestinal crypts. If you only target the mature surface cells, the therapy will be “washed away” in 3–5 days as the lining sheds. AAV6 and AAVrh10 have shown some ability to reach these progenitor cells when delivered via the blood supply (SMA).